华峰化学(002064)：一季度业绩承压 增强一体化优势

Core Insights - The company reported a revenue of 6.314 billion yuan for Q1 2025, a year-on-year decrease of 5.15%, and a net profit attributable to shareholders of 504 million yuan, down 26.21% year-on-year [1] - The decline in product prices, particularly for spandex and adipic acid, has put short-term pressure on performance, although spandex prices have started to recover since 2025, which may ease operational pressures for spandex manufacturers [1] - The company's comprehensive gross margin decreased by 2.66 percentage points to 13.47% due to the impact of falling product prices, affecting net profit growth [1] Production Capacity and Market Position - The company has a strong market position in the polyurethane industry, with spandex production capacity and output ranking second globally and first in China, as well as leading production in adipic acid and polyurethane raw materials in the country [1] - As of 2024, the company has a spandex production capacity of 325,000 tons, with an additional 150,000 tons under construction; adipic acid capacity is 1.355 million tons, and polyurethane raw material capacity is 520,000 tons [1] - The spandex capacity utilization rate reached 109.98% and adipic acid utilization rate was 94.96% in 2024, indicating high operational efficiency [1] Strategic Initiatives - The company is investing in upstream raw material projects, including a 1.1 million ton natural gas integration project and a 240,000 ton PTMEG spandex industry chain deepening project, which are expected to enhance cost advantages in spandex production [2] - The company is recognized as a leading enterprise in spandex, adipic acid, and polyurethane raw materials, with significant scale, technology, and cost advantages, and plans to continue strengthening its market position [2] Financial Forecast - The company maintains its profit forecast for 2025-2027, with projected net profits of 2.133 billion, 2.403 billion, and 2.664 billion yuan, respectively, corresponding to EPS of 0.43, 0.48, and 0.54 yuan [2] - The current stock price corresponds to P/E ratios of 16, 14, and 12 for the years 2025, 2026, and 2027, respectively, and the company maintains a "strong buy" rating [2]